Mutagenesis of the human 5-HT1B receptor: Differences from the closely related 5-HT1A receptor and the role of residue F331 in signal transduction

Journal of Receptor and Signal Transduction Research

Volumn 18, Issue 42100, 1998, Pages 225-241

  GrANAS C ^a   Nordvall, G ^a   Larhammar, D ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

5 CARBAMOYLTRYPTAMINE; CYCLIC AMP; FORSKOLIN; GUANINE NUCLEOTIDE BINDING PROTEIN; METHYSERGIDE; METITEPINE; SEROTONIN 1B RECEPTOR; SEROTONIN AGONIST; SEROTONIN ANTAGONIST; SUMATRIPTAN; TRITIUM;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CHO CELL; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIGAND BINDING; MOLECULAR INTERACTION; NONHUMAN; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ANIMALS; CHO CELLS; CRICETINAE; CYCLIC AMP; FORSKOLIN; GTP-BINDING PROTEINS; HUMANS; MUTAGENESIS, SITE-DIRECTED; RECEPTOR, SEROTONIN, 5-HT1B; RECEPTORS, SEROTONIN; SEROTONIN; SIGNAL TRANSDUCTION; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA; CRICETINAE; CRICETULUS GRISEUS; TRITIUM;

EID: 0032445730     PISSN: 10799893     EISSN: None     Source Type: Journal    
DOI: 10.3109/10799899809047745     Document Type: Article

References (28)

1. Kobilka B., Kobilka T., Daniel K., Regan J., Caron M., Lefkowitz R. Chimeric alpha 2-, beta 2-adrenergic receptors: delineation of domains involved in effector coupling and ligand binding specificity. Science 1988; 240: 1310 – 1316
2. Strader C., Sigal I., Dixon R. Structural basis of β-adrenergic receptor function. FASEB J. 1989; 7: 1825 – 1832
3. Lefkowitz R. J., Coteccia S., Samama P., Costa T. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins, Trends Pharmacol. Sci. 1993; 14: 303 – 307
4. Strader C. D., Fong T. M., Graziano M. P., Tota M. R. The family of G-protein-coupled receptors. FASEB J 1995; 9: 745 – 754
5. Hamblin M. W., Metcalf M. A. Primary structure and functional characterization of a human 5-HT1D-type serotonin receptor. Mol. Pharmacol. 1991; 40: 143 – 148
6. Boschert U., Amara D. A., Segu L., Hen R. The mouse 5-hydroxytryptamine1Breceptor is localized predominantly on axon terminals. Neuroscience 1994; 58: 167 – 182
7. Demchyshyn L., Sunahara R. K., Miller K., Teitler M., Hoffman B. J., Kennedy J. L., Seeman P., Van Tol H. H.M., Niznik H. B. A human serotonin1Dreceptor variant (5HT1Dβ) encoded by an intronless gene on chromosome 6. Proc. Natl Acad. Sci. U.S.A. 1992; 89: 5522 – 5526
8. Nordvall G., Hacksell U. Binding-site modeling of the muscarinic m1receptor – a combination of homology-based and indirect approaches. J. Med. Chem. 1993; 36: 967 – 976
9. Henderson R., Baldwin J. M., Ceska T. A., Zemlin F., Beckmann E., Downing K. H. Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J. Mol. Biol 1990; 213: 899 – 929
10. Fong T. M., Strader C. D. Functional mapping of the ligand binding sites of G-protein coupled receptors. Med. Res. Rev. 1994; 14: 387 – 399
11. Deng W. P., Nickoloff J. A. Site-directed mutagenesis of virtually any plasmid by eliminating a unique site. Anal. Biochem. 1992; 200: 81 – 88
12. Felgner P., Gadek T., Holm M., Roman R., Chan H., Wenz M., Northrop J., Ringold G., Danielsen M. Lipofection: a highly efficient, lipidmediated DNA-transfection procedure. Proc. Natl Acad. Sci. U.S.A. 1987; 84: 7413 – 7417
13. Markwell M. A.K., Haas S. M., Bieber L. L., Tolbert N. E. A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal. Biochem. 1978; 87: 206 – 210
14. Woodward R., Daniell S. J., Strange P. G., Naylor L. H. Structural studies on dopamine D2 receptors – mutation of a histidine residue specifically affects the binding of a subgroup of substituted benzamide drugs. J. Neurochem 1994; 62: 1664 – 1669
15. Hibert M. F., Trumpp K. S., Bruinvels A., Hoflack J. Three-dimensional models of cationic neurotransmitter G-protein coupled receptors. Mol. Pharmacol. 1991; 40: 8 – 15
16. Ho B. Y., Karschin A., Branchek T., Davidson N., Lester H. A. The role of conserved aspartate and serine residues in ligand binding and in function of the 5-HT1Areceptor: a site-directed mutation study. FEBS Lett. 1992; 312: 259 – 262
17. Strader C., Candelore M., Hill W., Sigal I., Dixon R. Identification of two serine residues involved in agonist activation of the β-adrenergic receptor. J. Biol. Chem 1989; 264: 13572 – 13578
18. Pollock N. J., Manelli A. M., Hutchins C. W., Steffey M. E., Mackenzie R. G., Frail D. E. Serine mutations in transmembrane V of the dopamine D1receptor affect ligand interactions and receptor activation. J. Biol. Chem. 1992; 267: 17780 – 17786
19. Cox B. A., Henningsen R. A., Spanoyannis A., Neve R. L., Neve K. A. Contributions of conserved serine residues to the interactions of ligands with dopamine D2receptors. J. Neurochem. 1992; 59: 627 – 635
20. Mansour A., Meng F., Meador-Woodruff J. H., Taylor L. P., Civelli O., Akil H. Site-directed mutagenesis of the human dopamine D2receptor. Eur. J. Pharmacol. 1992; 227: 205 – 214
21. Choudhary M. S., Craigo S., Roth B. L. A single point mutation (Phe340→Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2receptors. Mol. Pharmacol. 1993; 43: 755 – 761
22. Roth B. L., Choudhary M. S., Khan N., Uluer A. High-affinity binding is not sufficient for agonist efficacy at 5-hydroxytryptamine2Areceptors: evidence in favor of a modified ternary complex model. J. Pharmacol. Exp. Ther. 1997; 280: 576 – 583
23. Cho W., Taylor L. P., Mansour A., Akil H. Hydrophobic residues of the D2dopamine receptor are important for binding and signal transduction. J. Neurochem. 1995; 65: 2105 – 2115
24. Dixon R. A.F., Sigal I. S., Strader C. D. Structure-function analysis of the β-adrenergic receptor, Cold Spring Harbor Symp. Quant. Biol. 1988; 53: 487 – 497
25. Samama P., Coteccia S., Costa T., Lefkowitz R. J. A mutational-induced activated state of the β2-adrenergic receptor. J. Biol. Chem. 1993; 268: 4625 – 4636
26. Tiberi M., Caron M. G. High agonist-independent activity is a distinguishing feature of the dopamine D1Breceptor subtype. J. Biol. Chem. 1994; 269: 27925 – 27931
27. Kjelsberg M. A., Cotecchia S., Ostrowski J., Caron M. G., Lefkowitz R. J. Constitutive activation of the α1B-adrenergic receptor by all amino acid substitutions at a single site. J. Biol. Chem. 1992; 267: 1430 – 1433
28. Thomas D. R., Faruq S. A., Balcarek J. M., Brown A. M. Pharmacological characterisation of [35S]-GTPΓS binding to chinese hamster ovary cell membranes stably expressing cloned human 5-HT1Dreceptor subtypes. J. Receptor Signal Transduct. Res. 1995; 15: 199 – 211